Volume 68, Issue 3 | Page 8

PEDIATRICS THE MIS-C MYSTERY: PEDIATRIC COMPLICATIONS IN THE COVID-19 PANDEMIC AUTHOR Bethany Hodge, MD, MPH Throughout the weeks of anticipation of a viral pandemic coming to the US, pediatricians held on to one consolation: the kids seemed to be doing all right. We know that some of our population, such as premature babies and children with special health care needs, are extremely vulnerable to pulmonary pathogens, but overall the novel coronavirus appeared to be sparing children. We did not know why, but we were relieved. For a while, my experience of the pandemic was simply tense boredom. The census was way down across Norton Children’s Hospital, and most meetings and lectures were canceled. I pitched in to help my adult medicine colleagues as I could, volunteered for the Louisville Metro Department of Public Health & Wellness and tried to lower my personal protective equipment footprint. I actually spent a significant amount of time reading new literature while crocheting little button “ear-savers” for my masked colleagues. A month later, however, we were no longer sure that the kids were going to be all right. The first mentions of pediatric COVID-19-related multisystem inflammatory syndrome came out of the United Kingdom in late April 2020. In a case series describing eight patients, children who either had PCR or antibody diagnosis of SARS-CoV-2 infection later developed unexplained new symptoms of persistent fever with laboratory evidence of severe inflammation and multi-organ dysfunction. This was nothing like the acute respiratory distress syndrome killing adult patients slowly by asphyxiation, as the lungs did not seem to be the main target. The whole immune system appeared to be on fire, leading to every organ suffering and potentially death by complete cardiovascular collapse. In my role as a volunteer researcher with the Louisville Metro Department of Public Health & Wellness, I saw the early article from the U.K. and knew this was something that could potentially be headed to Kentucky. In early May, I got in contact with a University of Louisville School of Medicine graduate, Dr. Francesca Kingery, who was now the Chief Resident of pediatrics at Columbia University. She was working at New York-Presbyterian Hospital in one of the hardest hit areas of New York City. We exchanged some frantic texts on May 5. She warned me that a storm was coming. About a week later, we had our first recognized case in Louisville. This pediatric illness seems to come about 14 days after the peak of adult COVID-19 cases in an area, and ours was right on time. The first Centers for Disease Control and Prevention bulletin warning us of this new entity came out a few days after that. By then, the news outlets and social media were ramping up their coverage of the mystery illness. It was so new; we didn’t really even know what 6 LOUISVILLE MEDICINE